{
    "id": 5742,
    "name": "pancreatic acinar cell adenocarcinoma",
    "source": "DOID",
    "definition": "A pancreatic adenocarcinoma that has_material_basis_in cells with morphological resemblance to acinar cells and is associated with increased serum lipase. [url:http\\://en.wikipedia.org/wiki/Acinar_cell_carcinoma_of_the_pancreas, url:http\\://www.pathologyoutlines.com/topic/pancreasacinar.html]",
    "currentPreferredTerm": null,
    "lastUpdateDateFromDO": "03/24/2020",
    "altIds": [
        
    ],
    "termId": "DOID:5742",
    "evidence": [
        
    ],
    "clinicalTrials": [
        {
            "nctId": "NCT01537107",
            "title": "Sirolimus and Vismodegib in Treating Patients With Solid Tumors or Pancreatic Cancer That is Metastatic or Cannot Be Removed By Surgery",
            "phase": "Phase I",
            "recruitment": "Completed",
            "therapies": [
                {
                    "id": 1329,
                    "therapyName": "Sirolimus + Vismodegib",
                    "synonyms": null
                }
            ]
        },
        {
            "nctId": "NCT02834013",
            "title": "Nivolumab and Ipilimumab in Treating Patients With Rare Tumors",
            "phase": "Phase 0",
            "recruitment": "Recruiting",
            "therapies": [
                {
                    "id": 1627,
                    "therapyName": "Ipilimumab + Nivolumab",
                    "synonyms": null
                }
            ]
        },
        {
            "nctId": "NCT03412799",
            "title": "Study of SBP-101 Combined With Nab-Paclitaxel and Gemcitabine in Pancreatic Cancer",
            "phase": "Phase I",
            "recruitment": "Recruiting",
            "therapies": [
                {
                    "id": 7065,
                    "therapyName": "Gemcitabine + Nab-paclitaxel + SBP-101",
                    "synonyms": null
                }
            ]
        }
    ]
}